Zydus Lifesciences’ subsidiary, Zydus Lifesciences Global FZE, signed an exclusive licensing and supply agreement with Viwit Pharmaceuticals for two gadolinium-based MRI contrast agents targeting the US market.
The agreement includes the supply of gadobutrol injection, a generic version of Gadavist, and gadoterate meglumine injection, a generic version of Dotarem, which enhance visibility in MRI scans.
Viwit Pharmaceuticals will handle the ANDA submission, manufacturing, and supply of the generic versions of Gadavist™ and Dotarem upon receiving regulatory approval.
Zydus will take charge of marketing, distributing, and selling these MRI contrast agents in the US market, marking its entry into the contrast agent product category.
According to IQVIA MAT July 2024 data, the market for gadobutrol injection in the US is valued at $120 million, while gadoterate meglumine injection is estimated at $117 million.
On September 12, it was reported that the US FDA issued a warning to Zydus Lifesciences’ drug manufacturing facility in Jarod, Gujarat, following an April 2024 inspection.
The warning letter cited issues with cross-contamination, particulate contamination, and poor aseptic procedures, indicating inadequate current good manufacturing practices (CGMP) at the facility.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice